Meeting Abstract

Quality-controlled characterization of an EC5 specific monoclonal antibody against Desmoglein 3 as a standardized tool for preclinical pemphigus analysis


Authors listEming, R.; Müller, E.; Zakrzewicz, A.; Linne, U.; Tikkanen, R.; Hudemann, C.

Publication year2024

JournalExperimental Dermatology

Volume number33

Issue number3

ISSN0906-6705

eISSN1600-0625

DOI Linkhttps://doi.org/10.1111/exd.14994

Conference50th Annual Meeting of the Dermatological Research Working Group (ADF)

PublisherWiley



Citation Styles

Harvard Citation styleEming, R., Müller, E., Zakrzewicz, A., Linne, U., Tikkanen, R. and Hudemann, C. (2024) Quality-controlled characterization of an EC5 specific monoclonal antibody against Desmoglein 3 as a standardized tool for preclinical pemphigus analysis, Experimental Dermatology, 33(3), Article P112. https://doi.org/10.1111/exd.14994

APA Citation styleEming, R., Müller, E., Zakrzewicz, A., Linne, U., Tikkanen, R., & Hudemann, C. (2024). Quality-controlled characterization of an EC5 specific monoclonal antibody against Desmoglein 3 as a standardized tool for preclinical pemphigus analysis. Experimental Dermatology. 33(3), Article P112. https://doi.org/10.1111/exd.14994


Last updated on 2025-25-07 at 13:35